Menu

New Pesticide Affects Bumblebee Reproduction

Sulfoxaflor, an alternative insect-killer to older chemicals that decimate pollinators, turns out to kneecap colonies.

Aug 15, 2018
Shawna Williams

ABOVE: ISTOCK, ALLE12

Sulfoximines, a class of pesticides now being adopted worldwide as a replacement for compounds known to harm pollinators, themselves diminish queen bumblebees’ reproductive capacity, a new study finds. In a report published today (August 15) in Nature, researchers report that colonies founded by queens exposed to small amounts of sulfoxaflor, an insecticide that kills aphids, psyllids, and other pests, produce 54 percent fewer male drones than do unexposed colonies—and no new queen bees at all.

“Our study highlights that stressors that do not directly kill bees can still have damaging effects further down the line, because the health of the colony depends on the health of its workforce,” coauthor Elli Leadbeater of Royal Holloway University of London tells The Irish News.

Leadbeater and her coauthors captured wild queen bumblebees (Bombus terrestris) and fed them and their new colonies either a control sugar solution or one spiked with five parts per billion of sulfoxaflor—a level they based on estimates of what the insects would be exposed to in sprayed fields. After two weeks, they placed the colonies in a field, but continued monitoring them. A few weeks later, there were detectable differences in the numbers of worker bees in the exposed and unexposed colonies. And while 3 of the 26 control colonies produced new queen bees during the experiment, none of the exposed colonies yielded new queens.

See “Field Studies Confirm Neonicotinoids’ Harm to Bees

Unlike neonicotinoids, pesticides that have been found to impair pollen foraging, sulfoxaflor did not appear to impede bumblebees’ ability to get food, Nigel Raine of the University of Guelph writes in an accompanying commentary. “Perhaps early-stage colony growth and subsequent reproductive output were affected by sulfoxaflor toxicity to developing larvae, or by some other indirect mechanism—either way, the timing of declines in colony growth rate suggests that chronic sublethal stress at an early stage resulted in substantially reduced colony reproduction.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.